Clinical Trial Update: A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

This is a Phase Ib/III trial update for suvemcitug in combination with trifluridine/tipiracil for refractory metastatic colorectal cancer; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Suvemcitug
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Refractory Metastatic Colorectal Cancer | Phase 3 | Status: RECRUITING